Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin

The ABCG2 transporter protein, as part of several known mechanisms involved in multidrug resistance, has the ability to transport a broad spectrum of substrates out of the cell and is, therefore, considered as a potential target to improve cancer therapies or as an approach to combat drug resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Paskas, Svetlana, Stockmann, Philipp, Mijatović, Sanja, Kuhnert, Lydia, Honscha, Walther, Hey-Hawkins, Evamarie, Maksimović-Ivanić, Danijela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674596/
https://www.ncbi.nlm.nih.gov/pubmed/38004447
http://dx.doi.org/10.3390/ph16111582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674596/
https://www.ncbi.nlm.nih.gov/pubmed/38004447
http://dx.doi.org/10.3390/ph16111582

Ejemplares similares